Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 2
1(25.0%)
Phase 4
1(25.0%)
4Total
N/A(2)
Phase 2(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07396701Phase 4Not Yet Recruiting

Chinese Adaptive Randomised Pneumonia Trial With Respiratory Failure

Role: collaborator

NCT06921980Recruiting

Brain Function and Psychological Changes Related to Cell Therapy for Autoimmune Hemolytic Anemia

Role: collaborator

NCT06097013Enrolling By Invitation

Study of Brain Function Evaluation System for Acute and Prolonged Disorders of Consciousness

Role: collaborator

NCT05682248Not ApplicableEnrolling By Invitation

Study of Brain Function Evaluation and Intervention System for Acute and Prolonged Disorders of Consciousness

Role: collaborator

NCT02948660Phase 2Completed

A Promising Tool for Predicting Consciousness Evolution in Prolonged Disorders of Consciousness

Role: collaborator

NCT04667819Not ApplicableUnknown

Wireless Micropump in Dry Eye Patients

Role: collaborator

All 6 trials loaded